BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34625710)

  • 61. Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice.
    Zeineldin M; Miller MA; Sullivan R; Neufeld KL
    Carcinogenesis; 2014 Aug; 35(8):1881-90. PubMed ID: 24894865
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
    Angelou A; Papalois AE; Antoniou E; Wang J; Amini N; Pikouli A; Andreatos N; Buettner S; Munir M; Theodoropoulos G; Zografos GC; Sarantis P; Pulvirenti A; Kamphues C; Theocharis S; Pikoulis E; Margonis GA
    Anticancer Res; 2020 Oct; 40(10):5457-5462. PubMed ID: 32988867
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.
    Suzuki R; Kohno H; Sugie S; Nakagama H; Tanaka T
    Carcinogenesis; 2006 Jan; 27(1):162-9. PubMed ID: 16081511
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.
    Osman J; Savari S; Chandrashekar NK; Bellamkonda K; Douglas D; Sjölander A
    Oncotarget; 2017 May; 8(21):34773-34786. PubMed ID: 28410235
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice.
    Liu ZX; Chen WJ; Wang Y; Chen BQ; Liu YC; Cheng TC; Luo LL; Chen L; Ju LL; Liu Y; Li M; Feng N; Shao JG; Bian ZL
    World J Gastroenterol; 2022 Dec; 28(47):6752-6768. PubMed ID: 36620338
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemopreventive Effect of Aster glehni on Inflammation-Induced Colorectal Carcinogenesis in Mice.
    Chung KS; Cheon SY; Roh SS; Lee M; An HJ
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29439531
    [TBL] [Abstract][Full Text] [Related]  

  • 67. STING-mediated Syk Signaling Attenuates Tumorigenesis of Colitis‑associated Colorectal Cancer Through Enhancing Intestinal Epithelium Pyroptosis.
    Gong W; Liu P; Zhao F; Liu J; Hong Z; Ren H; Gu G; Wang G; Wu X; Zheng T; Zhao Y; Ren J
    Inflamm Bowel Dis; 2022 Mar; 28(4):572-585. PubMed ID: 34473281
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer.
    Mashtoub S; Chartier LC; Trinder D; Lawrance IC; Howarth GS
    Nutr Cancer; 2022; 74(2):715-723. PubMed ID: 33840308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mouse Models of Colitis-Associated Colon Cancer.
    Manicassamy S; Prasad PD; Swafford D
    Methods Mol Biol; 2021; 2224():133-146. PubMed ID: 33606212
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis.
    Vieira AT; Fagundes CT; Alessandri AL; Castor MG; Guabiraba R; Borges VO; Silveira KD; Vieira EL; Gonçalves JL; Silva TA; Deruaz M; Proudfoot AE; Sousa LP; Teixeira MM
    Am J Pathol; 2009 Dec; 175(6):2382-91. PubMed ID: 19893035
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
    Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
    Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma.
    Short SP; Barrett CW; Stengel KR; Revetta FL; Choksi YA; Coburn LA; Lintel MK; McDonough EM; Washington MK; Wilson KT; Prokhortchouk E; Chen X; Hiebert SW; Reynolds AB; Williams CS
    Oncogene; 2019 Jun; 38(25):5091-5106. PubMed ID: 30858547
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.
    Stolfi C; Rizzo A; Franzè E; Rotondi A; Fantini MC; Sarra M; Caruso R; Monteleone I; Sileri P; Franceschilli L; Caprioli F; Ferrero S; MacDonald TT; Pallone F; Monteleone G
    J Exp Med; 2011 Oct; 208(11):2279-90. PubMed ID: 21987656
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
    Xu H; Li J; Chen H; Ghishan FK
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth.
    Rigoni A; Bongiovanni L; Burocchi A; Sangaletti S; Danelli L; Guarnotta C; Lewis A; Rizzo A; Silver AR; Tripodo C; Colombo MP
    Cancer Res; 2015 Sep; 75(18):3760-70. PubMed ID: 26206557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
    Tian Y; Xu Q; Sun L; Ye Y; Ji G
    J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
    Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
    Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
    Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blocking NFATc3 ameliorates azoxymethane/dextran sulfate sodium induced colitis-associated colorectal cancer in mice via the inhibition of inflammatory responses and epithelial-mesenchymal transition.
    Lin Y; Koumba MH; Qu S; Wang D; Lin L
    Cell Signal; 2020 Oct; 74():109707. PubMed ID: 32653643
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model.
    Liu Y; Fang X; Yuan J; Sun Z; Li C; Li R; Li L; Zhu C; Wan R; Guo R; Jin L; Li S
    Endocr Relat Cancer; 2014 Aug; 21(4):639-51. PubMed ID: 25015995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.